Leonteq Securities’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPRX
Leonteq Securities's CPRX Position: Q3 2026 in Review
Leonteq Securities sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 1,912 shares — an estimated $60.1K sold.
Leonteq Securities first reported a position in CPRX in Q2 2021 and held it in 13 quarters. The position peaked at $98.2K in Q1 2026. 2 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.
- Leonteq Securities reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- Leonteq Securities sold 1,912 Catalyst Pharmaceutical shares in Q3 2026, an estimated $60.1K.
- Leonteq Securities first reported a position in Catalyst Pharmaceutical in Q2 2021 and held it in 13 quarters.
- Leonteq Securities's Catalyst Pharmaceutical position peaked at $98.2K in Q1 2026.
- 2 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.